Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizures, Focal”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Not applicableWithdrawnNCT05738226
What this trial is testing

EpiCare@Home Validation Study for Focal Onset Seizures

Who this might be right for
EpilepsySeizuresSeizures, Focal+1 more
Byteflies
Large-scale testing (Phase 3)Study completedNCT01392768
What this trial is testing

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

Who this might be right for
EpilepsyPartial Seizures
Ache Laboratorios Farmaceuticos S.A. 126
Not applicableActive Not RecruitingNCT05248269
What this trial is testing

Thermocoagulation in Drug Resistant Focal Epilepsy

Who this might be right for
EpilepsySeizures, FocalEpilepsy Intractable+1 more
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Large-scale testing (Phase 3)Study completedNCT03250377
What this trial is testing

Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Partial Seizures With or Without Secondary GeneralizationEpilepsy
UCB Biopharma SRL 207
Post-approval studies (Phase 4)Ended earlyNCT01266291
What this trial is testing

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Who this might be right for
Complex Partial Seizures
University of Pennsylvania 1
Post-approval studies (Phase 4)Ended earlyNCT05605756
What this trial is testing

BOTOX Effects on Seizure Severity and Susceptibility

Who this might be right for
Drug-resistant Focal Seizure
Beth Israel Deaconess Medical Center 3
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00957372
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 253
Testing effectiveness (Phase 2)Study completedNCT01159431
What this trial is testing

External Trigeminal Nerve Stimulation for Epilepsy

Who this might be right for
EpilepsySeizure Disorders
Olive View-UCLA Education & Research Institute 50
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Not applicableEnded earlyNCT02261753
What this trial is testing

Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy

Who this might be right for
Cortical Dysplasia
University College, London 3
Post-approval studies (Phase 4)Study completedNCT01630057
What this trial is testing

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Who this might be right for
Partial Seizures
Eisai Inc. 200
Large-scale testing (Phase 3)Study completedNCT03340064
What this trial is testing

Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Who this might be right for
Partial Seizures
UCB Japan Co. Ltd. 38
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Testing effectiveness (Phase 2)Study completedNCT03283371
What this trial is testing

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Who this might be right for
Epilepsy, Focal Seizures, Partial Seizures
Biogen 67
Not applicableUnknownNCT02462551
What this trial is testing

Focal Electrically Administered Seizure Therapy for the Treatment of Depression

Who this might be right for
Treatment-Resistant Depression
Ziad Nahas 30
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Not applicableLooking for participantsNCT06466681
What this trial is testing

Changes in Attentional Control After a Focal Seizure.

Who this might be right for
Temporal Lobe EpilepsyFrontal Lobe EpilepsyOthers Subtypes
University Hospital, Lille 100
Large-scale testing (Phase 3)Study completedNCT01262677
What this trial is testing

Once-A-Day Pregabalin For Partial Seizures

Who this might be right for
Partial SeizuresEpilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Post-approval studies (Phase 4)Ended earlyNCT00165828
What this trial is testing

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
Eisai GmbH 157
Load More Results